ABSTRACT. The extent of in vivo lipid peroxidation and the in vivo antioxidant effects of a-tocopherol and atocopheryl acetate were studied in newborn rabbits exposed to one of two oxidant stresses: hyperoxia (FIO~ >0.9) or parenteral lipid emulsion infusion. Lipid peroxidation was monitored by measurement of expired ethane and pentane, tissue thiobarbituric acid (TBA) reactants, and tissue lipid peroxides. Seventy-two h of hyperoxia did not increase any of the parameters of lipid peroxidation although mortality was higher in oxygen exposed animals. a-Tocopherol (100 mg/kg, intravenous) lowered expired hydrocarbons and tissue TBA reactants, but raised liver lipid peroxides in both air and hyperoxia exposed pups. Infusion of soybean oil emulsion increased production of ethane and pentane, liver TBA reactants, and lung lipid peroxides. Both atocopherol and a-tocopheryl acetate prevented the soybean oil emulsion induced increase in volatile hydrocarbons. aTocopherol (100 mg/kg, intravenous) administration also prevented the increase in liver TBA reactants and lung lipid peroxides. In identically treated animals, a-tocopheryl acetate administration decreased liver TBA reactants but had no effect on lung lipid peroxides. We conclude that atocopherol reduces lipid peroxidation in newborn rabbits including animals exposed to hyperoxia or infused with lipid emulsions. a-Tocopheryl acetate results in lower tissue a-tocopherol concentrations and is less effective as an antioxidant in lipid emulsion infused rabbits. (Pediatr Res 20: 505-510,1986) Abbreviations TBA, thiobarbituric acid LOOH, lipid hydroperoxides LOO -, lipid peroxy radicals Modern neonatal care has improved the survival of low birth weight infants. Paramount for the survival of the low birth weight infant is the use of increased oxygen concentrations to support an immature cardiorespiratory system. However, the reduction in mortality has been associated with an increase in chronic morbidities. Among these are several complications associated
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The exact mechanism by which oxidant tissue damage occurs is not clear. Several lines of evidence support the hypothesis that oxidant injury is mediated by the generation of partially reduced oxygen species (1) (2) (3) . These reactive species may damage tissues by peroxidation of lipids, oxidation of proteins and nucleic acids, or through yet undefined mechanisms. It has long been presumed that polyunsaturated fatty acids in membranes are particularly susceptible to oxidative processes, and that "lipid peroxidation" is a central feature of oxygen-associated tissue damage. Lipid peroxidation is associated with the generation of lipid-derived intermediate products including lipid hydroperoxides, hydroxyaldehydes, and malonaldehyde. These intermediates may be important in the damage process, because they also are very reactive and can propagate further oxidizing reactions (4) .
The mature human organism vossesses vrotective mechanisms to detoxify both reactive Exygen metabolites and the lipid-derived intermediates. These include enzymatic (superoxide dismutase, catalase, and the glutathione system) and nonenzymatic factors (sulfhydryl containing amino acids and vitamins E and C) (3).
In the newborn, particularly the preterm newborn, protective systems may not be fully active, in part because the nutritional sources of antioxidant vitamins and necessary cofactors for the protective enzymes are insufficient (5, 6). Despite these "deficiencies," most newborn animal species appear to be resistent to oxygen-induced toxicities (7) . However, the conclusion that newborns are resistant to oxidative injury is based on mortality data which may not reflect the importance of vitamin E and the antioxidant enzyme systems to individual tissues or organs. For example, newborn animals suffer severe lung damage after exposure to hyperoxia ( 9 , and their resistence to oxygen-related mortality may reflect the ability of metabolically active tissues to repair themselves. Despite the unresolved questions regarding the biochemical origin of oxygen-induced injury, vitamin E has been administered to neonates in an attempt to protect against oxygen-induced tissue damage. Although the therapeutic experience with vitamin E is now extensive, controversy continues regarding the appropriate indications and dosage for vitamin E therapy (8, 9) .
This report presents the results of experiments designed to test the hypothesis that lipid peroxidation is increased by oxidative challenges in the newborn. Three experimental conditions were utilized to explore the extent of lipid peroxidation in newborns. The first experiments examined the effect of oxygen on biochemical parameters of in vivo lipid peroxidation in newborn rabbits.
To further test the hypothesis that hyperoxic exposure increases in vivo lipid peroxidation, the antioxidant effectiveness of atocopherol was examined in newborn rabbits exposed to room air or hyperoxia. The final series of experiments examined the parameters of lipid peroxidation after infusion of lipid emulsions while comparing the relative antioxidant effectiveness of a-tocopherol and a-tocopheryl acetate. The acetate ester of the 506 WISPE ET AL. naturally occurring isomer is the commercial form of vitamin E oil emulsion (Intralipid, lo%, Cutter Biological, Emeryville, CA). most commonly available. However, the esterified form is prob-Soybean oil emulsion was used because it contains approximately ably not active as an antioxidant until the acetate group is 5-10 mg/liter of a-tocopherol, compared to safflower oil emulremoved (10) . In addition, the tissue disposition of intravenous sion which contains 25-30 mg/liter (1 3). Indwelling intravenous a-tocopheryl acetate is very different from that of a-tocopherol lines were placed, and a-tocopherol or a-tocopheryl acetate (100 (8) . We compared these two forms of vitamin E in newborn mg/kg), or vehicle placebo (2 ml/kg) was given intravenously rabbits receiving lipid emulsion infusion, a clinically relevant immediately prior to lipid emulsion infusion. a-Tocopherol was situation in which lipid peroxidation is increased. administered as obtained from Hoffmann-LaRoche. As outlined above, the vehicle for the Hoffmann-LaRoche preparation dif-
MATERIALS AND METHODS
fers from other available parenteral preparations. Pure a-tocopheryl acetate (Sigma Chemical, St. Louis, MO) was formulated The studies to investigate our objectives were conducted in in the same Emulphor 620 containing vehicle as the Hoffmannthree separate protocols. White New Zealand pregnant rabbits of LaRoche a-tocopherol. ,411 lipid infused animals received an known gestation, purchased from Morrison Rabbitry (West average dose of 3.7 g of lipid /kg, infused over 20 h. The pups Branch, 1.41, were delivered by cesearian section on day 31 of were studied for production of volatile hydrocarbons following gestation using 2.5% halothane in oxygen and local anesthesia completion of the lipid infusion. The animals were then killed, with 1% lidocaine. After delivery, the pups were placed in an and liver and lungs removed for determination of tissue TBA infant isolette (Air Shields, Inc., Hatboro, PA) with an air tem-reactants, tissue a-tocopherol and a-tocopheryl acetate concenperature of 34" C. After a 1-h recovery period, the pups were trations, and tissue lipid peroxide content. weighed, marked, and one of three protocols instituted. None of Analysis of hydrocarbons. Hydrocarbons were analyzed using the PUPS in these studies received any enteral feeding% but all gas-liquid chromatography as previously described (14, 15 ). Anreceived twice daily parenteral fluids consisting of glucose and imals were placed in a 1 .4-liter glass-topped, stainless steel chamelectrolytes (1 m1/10 g body weight) by subcutaneous clysis.
ber which was part of a closed, recirculating system. The atmosRoom air versus hyperoxia. The first Set of experiments was phere in the closed system was circulated continuously through designed to study the effects of hyperoxia (F102 >0.9) on lipid soda lime. Oxygen consumption was monitored by means of a peroxidation in the presence or absence of a-tocopherol. Imme-water manometer, and the oxygen consumed replaced with diately after delivery, Pups in each litter were randomized into hydrocarbon-free oxygen. For analysis of hydrocarbons in the two groups, one-half of the pups were placed in room air and expired air of the rabbit, a 6-ml aliquot of gas from the closed the other half in hyperoxia. The duration of exposure was 3 days. system was injected into the gas chromatograph via a six-way One half of the animals in both the room air and the hyperoxia valve connected to the recirculating system. Hydrocarbon congroups received 100 mg/kg of a-tocopherol (provided by Hoff-tent of the system was measured at the beginning and the end of mann-LaRoche, Nutley, NJ) intravenously at 4 h of age. The a 60-min period. The difference in ethane and pentane between Hoffman-LaRoche product is compounded in 10% Emulphor the two samples represented hydrocarbons excreted by the rabbit 620 (a polyoxyethylated vegetable oil), 10% ethyl alcohol, 10% pup. The rate of hydrocarbon production is expressed as pmol/ propylene glycol, 0.03% sodium acetate, 0.25% acetic acid, 100 g body weight per min. 0.0 1 % EDTA, and 0.9% saline. The pH is adjusted to 4 with
Analysis of thiobarbituric acid reactants. Lung and liver TBA sodium hydroxide (I I). Vehicle-treated controls received this reactants were quantitated on fresh tissue. The organs were same preparation without vitamin E. Expired ethane and Pentane removed, washed in cold isotonic phosphate buffer, and carefully were quantitated in each rabbit at the end of the 3-day exposure blotted dry. One hundred mg of tissue were homogenized in ice period. After analysis of expired hydrocarbons, the animals were cold aqueous 1.15 % KC1. For the first two protocols, liver and killed with sodium pentobarbital (intra~eritoneal), and blood, lung TBA reactants were quantitated spectrophotometrically liver, and lungs removed for analysis of a-tocopherol concentra-(1 6), and the results reported as the difference between absorption tion, TBA reactants, and lipid peroxides. of 532 and 520 nm. For the soybean oil emulsion studies, tissue
Safflower oil emulsion infusion. Previously we have shown that TBA reactants (Table 7) were quantitated using a modification infusion of safflower oil emulsion (Lipos~n 10% Abbott Labo-of the fluorometric method (17) . To prevent the production of ratories, Chicago, IL) increases expired pentane in newborn TBA reactants during the assay procedure (l8), 1 mM deferoxhumans and rabbits (1 1). The second series of experiments was amine was added to each homogenate. Blood TBA reactants designed to evaluate the antioxidant effects of a-tocopherol on were determined by the fluorometric micromethod of Yagi (19) . lipid emulsion-enhanced lipid peroxidation in the newborn rabOther analyses. Tissue vitamin E concentrations were quantibit. The pups that received safflower oil emulsion without vita-tated using high-pressure liquid chromatography (20) which min E have been reported previously (12) , and are included in measures both a-tocopherol and a-tocopheryl acetate. this report to facilitate comparison with littermates that received Lipid peroxides present in the lungs and liver were measured safflower oil emulsion and vitamin E. Within 8 h of delivery, the as described by Hicks and Gebicki (2 1). This assay measures the pups were anesthetized with 15 mg/kg of sodium pentobarbital release of triiodide ions when peroxides present in tissue extracts intraperitoneally and indwelling intravenous catheters (24 gauge, react anaerobically with excess potassium iodide. Critikon, Inc., Tampa, FL) inserted into the right external jugular Statistical analysis. Parametric tests for significance at the p < vein. One-half of the pups received a single, intravenous dose of 0.05 level were used. For the air versus hyperoxia protocol, data 100 mg/kg of a-tocopherol immediately prior to beginning the were analyzed with a two-way ANOVA. Data from both lipid lipid emulsion infusion. The other half of the pups did not emulsion infusion protocols were analyzed with a one-way ANreceive a-tocopherol. The average dose of lipid was 4 g/kg for OVA. Newman-Keulspost hoc analyses were performed on those both groups and was administered by continuous infusion Over ANOVAS which were significant (22) . 20 h. Littermate, control animals, received parenteral glucose and electrolytes but no lipid emulsion, a-tocopherol, or vehicle. All pups were studied for production of volatile hydrocarbons at RESULTS the conclusion of the 20 h lipid infusion and then killed and blood, liver, and lungs removed for determination of a-tocoph-
The effect of oxygen on lipid peroxidation in newborn rabbits erol concentration and TBA reactants.
that did not receive a-tocopherol is shown in Table 1 . Animals
Soybean oil emulsion infusion. The relative antioxidant effec-not given a-tocopherol had a 3-day mortality of 40% in hypertiveness of a-tocopherol and a-tocopheryl acetate was compared oxia and 0% in room air. However the 72-h exposure to hyperin newborn rabbits receiving a continuous infusion of soybean oxia did not significantly increase pentane production, TBA 
infusion in newborn rabbits
The effect of a-tocopherol on lipid peroxidation in newborn 24-H lipid Pentane? rabbits is shown in Table 2 . Because there were no statistical dose differences between the room air-and hyperoxia-treated animals, (pmol/ 100 g/ Groups* (g/kg/da~) min) the data in Table 2 11 + 8 ceived a-single, intravenous dose of 100 mg/kg of a-tocopherol. a-Tocopherol also lowered TBA reactants in lung, liver, and blood. Lung and liver lipid peroxides with and without a-tocopherol also are shown in Table 2 . Three days after administration of a-tocopherol, lipid peroxides in liver were significantly higher in the pups treated with a-tocopherol than in the vehicletreated pups. All the differences between a-tocopherol treated pups and controls are consistent, even when the data are separately analyzed within air or hyperoxia groups. The tissue atocopherol concentrations of these animals 3 days after vitamin E administration are shown in the lower portion of Table 2 . aTocopherol, 100 mg/kg, significantly raised a-tocopherol concentrations in lung and liver.
In the second series of studies, the effect of intravenous atocopherol on lipid emulsion-enhanced lipid peroxidation was studied. These data are shown in Table 3 . All pups, except control, received approximately 4 g of lipid/kg during a 20-h infusion. Control pups received only parenteral fluids and no lipid emulsion or a-tocopherol. Safflower oil emulsion infusion increased expired pentane, but not ethane. Administration of a single, intravenous, 100 mg/kg dose of a-tocopherol significantly lowered expired pentane to levels that were not different from nonlipid infused controls. The TBA reactant data from these pups are shown in Table 4 . Lung, liver, and blood TBA reactants were increased by safflower oil emulsion infusion when com-*Control rabbits received no treatments. Lipid treated rabbits were infused with lipid emulsion over 20 h; lipid-and a-tocopherol-treated rabbits were given a-tocopherol (100 mg/kg intravenous) prior to lipid infusion. Values represent mean f SD.
1-Production of ethane was not different among any of the treatment groups. $ p < 0.05; control versus lipid.
5 p < 0.05; lipid versus lipid + a-tocopherol.
pared to nonlipid infusion controls that did not receive atocopherol. Administration of 100 mg/kg of a-tocopherol prevented the rise in liver and blood TBA reactants. Lung TBA reactants in animals given lipid emulsion and a-tocopherol were intermediate between the other two treatment groups and not statistically different from either.
In the third and final series of experiments, the relative antioxidant effectiveness of a-tocopherol and a-tocopheryl acetate was compared in soybean oil emulsion-infused pups. a-Tocopherol tissue concentrations in these animals are shown in Table 5 . Administration of a-tocopheryl acetate resulted in lower a-tocopherol concentrations compared to pups given the same dose of a-tocopherol. Lung a-tocopherol concentrations after a-tocopheryl acetate were not different from vehicle-treated pups. Animals given a-tocopheryl acetate also had 250 and 35 pg/g tissue of a-tocopheryl acetate in lung and liver, respectively. Vehicle placebo (n = 5) 6 + 4 2 + 3 *All animals received 4 g lipid/kg body weight over 20 h prior to analysis, and 100 mg/kg of a-tocopherol equivalents as a-tocopherol or a-tocopheryl acetate intravenously immediatley prior to initiation of lipid emulsion infusion. Vehicle placebo-treated animals received lipid emulsion and an equivalent volume of Emulphor 620 vehicle. Data from these experimental protocol are also presented in Tables 6 and 7. t p < 0.05; different from the other two treatment groups.
$ a-Tocopheryl acetate-treated animals also had 250 + 350 and 35 + 25 pg/g of a-tocopheryl acetate in lung and liver, respectively. 5 p < 0.05; different from the other two treatment groups. Table 6 presents the ethane and pentane data from the pups that received 10% soybean oil emulsion. Lipid-infused pups that received vehicle placebo produced more ethane and pentane than either a-tocopherol or a-tocopheryl acetate-treated pups. There were no differences in expired hydrocarbons between atocopherol and a-tocopheryl acetate treated pups. The tissue TBA reactant data and lipid peroxide data from these animals are shown in Table 7 . TBA reactants were quantitated fluorometrically (17) using 1 mM deferoxamine to prevent in vitro formation of reactant material (1 8) . Because different TBA assay methods were used, the data in Table 7 are not comparable to TBA data in Tables 1,2 , and 4. Compared to nontreated controls, soybean oil emulsion infusion in the vehicle-treated pups increased liver TBA reactants and lung lipid peroxides. Both atocopherol and a-tocopheryl acetate prevented the rise in liver TBA reactants after soybean oil emulsion infusion. However, only a-tocopherol prevented the increase in lung lipid peroxides after soybean oil emulsion infusion. a-Tocopherol also reduced lung TBA reactants below control levels. DISCUSSION Recently there have been considerable, and often divergent, discussions about the value of increasing antioxidant capabilities in newborn human infants by pharmacologically supplementing with vitamin E (8, 23, 24) . However, until recently it has not been possible to assess rigorously the contributions of lipid peroxidation to tissue injury or the antioxidant effectiveness of vitamin E, in part because of difficulty in quantitating oxidizing reactions in vivo (25) . Various products of lipid peroxidation have been measured in attempts to define the extent of in vivo lipid peroxidation and the antioxidant activity of vitamin E (10, 26) . Lipid hydroperoxides (LOOH) are intermediate products of polyunsaturated fatty acid peroxidation that can be measured directly in tissues. These peroxides can decompose to several products including malonaldehyde and volatile hydrocarbons. Malonaldehyde can be quantitated by reacting it with TBA, forming a chromophore with characteristic absorption and fluorescence spectra (27) . Volatile hydrocarbons are produced by degradation of lipid hydroperoxides and are a sensitive index of lipid peroxidation which correlates well with other biochemical and morphologic parameters of lipid peroxidation (26, 28) . In order to assess in vivo lipid peroxidation and antioxidant capabilities of vitamin E, we measured LOOH, TBA reactants, and volatile hydrocarbons in newborn rabbits treated with two clinically relevant oxidant stresses (oxygen, unsaturated lipids). Our first objective was to investigate the effect of hyperoxia on lipid peroxidation. In rabbit pups, given no nutritional sources of vitamin E or other antioxidants, a 3-day exposure to oxygen (F102 >O.9) did not significantly increase any of the measured biochemical parameters of lipid peroxidation. These findings are in contrast to the increased mortality in the oxygen-treated pups (Table I) , and to the subjective impression that the oxygen survivors were in worse condition than the room air controls. Caution is urged in applying these data to overall conclusions about the contribution of lipid peroxidation in oxygen-associated damage. The biochemical processes of oxidative damage are the result of complex interactions between damaging and protective reactions, therefore focusing on a single component of the system can be misleading. Lipid peroxidation cannot be excluded as a mechanism for oxygen-associated tissue damage, because our results may reflect technical difficulties in assessing lipid peroxidation in vivo. However, these results do suggest that other oxidative reactions are likely to be important.
Our second objective was to examine the effects of a-tocopherol on lipid peroxidation in newborn rabbits. A single injection of a-tocopherol decreased lung, liver, and blood TBA reactants, and expired pentane in newborn rabbits exposed to either room air or hyperoxia. However, in these animals, a-tocopherol administration increased liver, but not lung, lipid peroxides. These seemingly divergent effects are consistent with the antioxidant actions of a-tocopherol. One accepted mechanism of action for a-tocopherol is proton donation to reactive lipid species, particularly (LOO. ) ( 10) . The increased tissue a-tocopherol concentrations that result from a single, large dose of a-tocopherol could convert LOO. to the more stable lipid peroxides (LOOH) thus decreasing peroxy radical decomposition to TBA reactants and volatile hydrocarbons. After a intravenous dose of a-tocopherol, a-tocopherol levels are much higher in the liver than the lung (8) . If the effect of a-tocopherol on lipid peroxide formation is concentration dependent, then this difference in a-tocopherol tissue concentrations may explain why liver, but not lung, lipid peroxides were increased after a-tocopherol. Knight et al. (29) observed a 50% reduction in in vitro lipid peroxidation in lung with a-tocopherol concentrations of 30-100 pg/g. These values are close to the a-tocopherol concentrations which appeared to be necessary in our in vivo studies (Tables 5 to 7 ). Activity of other enzymes, particularly glutathione peroxidase, also are important in determining tissue TBA reactants and lipid peroxides (30) . Activity of glutathione system enzymes is greater in liver than lung and may also explain the differences between liver and lung lipid peroxide levels after a-tocopherol.
In vivo lipid peroxidation is increased by infusion of lipid emulsions in newborn humans and rabbits (12) , and provides another model in which to study antioxidant effects of vitamin E. Human infants have decreased clearance of infused lipids (3 1) and the triglycerides in the lipid emulsions may increase blood and tissue fatty acid content. If usual metabolic pathways are saturated, these fatty acids would then be available for alternative reactions including both nonenzymatic and enzymatic lipid peroxidation. Because the rate limiting step in in vivo eicosanoid formation is the availability of substrate fatty acids, lipid emulsion-associated increases in fatty acids may increase the rate of eicosanoid formation. Lipid peroxides are one of the intermediate products in arachadonic acid oxidation (32); these oxidation reactions can also generate TBA reactants and pentane (33, 34) . The data presented herein confirm the hypothesis that lipid peroxidation is increased by infusion of lipid emulsion preparations but do not clarify which specific pathways or reactions are involved. Vitamin E is an effective antioxidant and when present in supraphysiologic amounts may have significant effects on eicosanoid formation in vivo. In vitro, vitamin E inhibits fatty acid release from phospholipids, inhibits lipoxygenase activity, and stimulates prostacyclin production (35) . Thus, the "antioxidant actions" of vitamin E may have differential effects on lipid peroxidation depending on substrate availability and predominant oxidative pathways.
The third objective of these studies was to compare the antioxidant effectiveness of a-tocopherol and a-tocopheryl acetate in rabbit pups administered soybean oil emulsions. The acetate ester of a-tocopherol may not be an antioxidant until the acetate group is replaced by a hydrogen. Although hydrolysis of the ester linkage occurs, a-tocopherol concentrations in lung and liver after intravenous a-tocopheryl acetate administration are lower than after intravenous a-tocopherol (Table 5 ) (8) . Despite these differences in tissue tocopherol concentrations, both forms of vitamin E prevented the increases in expired ethane and pentane after infusion of soybean oil emulsion (Table 6 ). However, there were differences in tissue TBA reactants and lipid peroxides after a-tocopherol or a-tocopheryl acetate treatment. These differences appeared to be directly related to differences in tissue atocopherol concentrations. Administration of a-tocopherol increased lung and liver a-tocopherol concentrations and lowered lung and liver TBA reactants, and lung lipid peroxides. aTocopheryl acetate administration increased only liver a-tocopherol concentrations and lowered only liver TBA reactants; lung TBA reactants and lung lipid peroxides remained unchanged.
In newborn rabbits, infusion of either safflower or soybean oil lipid emulsion increased expired hydrocarbons. Infusion of soybean oil emulsion increased both expired ethane and pentane, while safflower oil emulsion increased only expired pentane (Table 3 versus 6). Dumelin and Tappel (36) demonstrated that production of specific hydrocarbons in vitro depends on the location of the w double bond in the oxidized fatty acid. Ethane evolves from w3 unsaturated fatty acids and pentane from w6 fatty acids. Therefore, the observed increase in pentane without a change in ethane production after infusion of safflower oil emulsion (Table 3) is consistent with the lipid composition of this emulsion; 77% linoleic acid (w6) and no linolenic acid (w3). Similarly, the increase in both ethane and pentane after infusion of soybean oil emulsion (Table 6 ) is consistent with soybean oil composition; 54% linoleic acid (w6) and 8% linolenic acid (w3).
Our results are similar to those reported by Wender et al. (37) .
In their study, rabbit pups fed a corn oil diet and exposed to hyperoxia had increased lung TBA reactants and increased erythrocyte hemolysis in hydrogen peroxide. Daily intramuscular injections of 20 mg/kg of a-tocopherol prevented both of these increases. However, oxygen alone did not increase hydrogen peroxide-induced erthrocyte hemolysis; and lung TBA data from air exposed pups were not available for comparison with the lung TBA data from oxygen-exposed pups. It is possible that the fatty acids in the corn oil (58% linoleic acid), and not the oxygen exposure, resulted in the increased lipid peroxidation. This conclusion is consistent with a previous report from our laboratory (14) and with the data in this report in which hyperoxia alone does not increase lipid peroxidation. Thus, the report from Wender et al. (37) may provide an enteral equivalent to our parenteral lipid infusion data.
In summary, this report demonstrates that high concentrations of oxygen alone do not increase lipid peroxidation above control values. Parenteral vitamin E decreases in vivo lipid peroxidation, however, a-tocopheryl acetate is a less effective antioxidant than a-tocopherol. The antioxidant effects seen in newborn rabbits justify a continued interest in the use of vitamin E, but also emphasize the need to understand better its sites, and mechanism, of action. The physiologic and metabolic consequences of changes in fatty acid oxidation, eicosanoid formation, and biologic radical generation and degradation are incompletely understood. The effects of large doses of a-tocopherol on these enzymatic and nonenzymatic lipid peroxidation reactions may have major biologic significance.
